Chimerix Inc (NASDAQ: CMRX)’s stock price has plunge by -7.42relation to previous closing price of 1.01. Nevertheless, the company has seen a -3.60% plunge in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-07 that Chimerix, Inc. (NASDAQ:CMRX ) Q3 2024 Earnings Call November 7, 2024 8:30 AM ET Company Participants Will O’Connor – Investor Relations Mike Andriole – President and Chief Executive Officer Josh Allen – Chief Scientific Officer Michelle LaSpaluto – Chief Financial Officer Allen Melemed – Chief Medical Officer Tom Riga – Chief Operating and Commercial Officer Conference Call Participants Maury Raycroft – Jefferies Operator Good morning, ladies and gentlemen and welcome to the Chimerix Third Quarter 2024 Earnings Conference Call. I would now like to introduce you to your host for today’s call, Will O’Connor from Stern Investor Relations.
Is It Worth Investing in Chimerix Inc (NASDAQ: CMRX) Right Now?
The 36-month beta value for CMRX is at 1.06. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 5 as “hold,” and 1 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CMRX is 79.93M, and currently, shorts hold a 2.17% of that float. The average trading volume for CMRX on November 08, 2024 was 444.46K shares.
CMRX’s Market Performance
CMRX stock saw an increase of -3.60% in the past week, with a monthly gain of 5.08% and a quarterly increase of 14.03%. The volatility ratio for the week is 9.88%, and the volatility levels for the last 30 days are 7.08% for Chimerix Inc (CMRX). The simple moving average for the last 20 days is 2.10% for CMRX stock, with a simple moving average of -1.86% for the last 200 days.
Analysts’ Opinion of CMRX
Many brokerage firms have already submitted their reports for CMRX stocks, with Robert W. Baird repeating the rating for CMRX by listing it as a “Outperform.” The predicted price for CMRX in the upcoming period, according to Robert W. Baird is $7 based on the research report published on May 23, 2023 of the previous year 2023.
CapitalOne, on the other hand, stated in their research note that they expect to see CMRX reach a price target of $7. The rating they have provided for CMRX stocks is “Overweight” according to the report published on September 07th, 2022.
Maxim Group gave a rating of “Buy” to CMRX, setting the target price at $20 in the report published on April 29th of the previous year.
CMRX Trading at 4.22% from the 50-Day Moving Average
After a stumble in the market that brought CMRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.07% of loss for the given period.
Volatility was left at 7.08%, however, over the last 30 days, the volatility rate increased by 9.88%, as shares surge +7.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.17% lower at present.
During the last 5 trading sessions, CMRX fell by -3.60%, which changed the moving average for the period of 200-days by +2.09% in comparison to the 20-day moving average, which settled at $0.9158. In addition, Chimerix Inc saw -2.85% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CMRX starting from Michael Andriole, who proposed sale 1,500 shares at the price of $0.87 back on Aug 08 ’24. After this action, Michael Andriole now owns shares of Chimerix Inc, valued at $1,300 using the latest closing price.
Andriole Michael T., the PRESIDENT AND CEO of Chimerix Inc, sale 1,285 shares at $0.83 during a trade that took place back on Aug 08 ’24, which means that Andriole Michael T. is holding 462,453 shares at $1,065 based on the most recent closing price.
Stock Fundamentals for CMRX
Current profitability levels for the company are sitting at:
- -657.78 for the present operating margin
- -255.53 for the gross margin
The net margin for Chimerix Inc stands at -588.2. The total capital return value is set at -0.61. Equity return is now at value -44.62, with -40.37 for asset returns.
Based on Chimerix Inc (CMRX), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -45.04. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -33.28.
Currently, EBITDA for the company is -93.06 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 483.82. The receivables turnover for the company is 1.12for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.94.
Conclusion
In conclusion, Chimerix Inc (CMRX) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
